Wednesday, September 23, 2026

BancorpSouth And 3 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

ViaNews Editorial Team

September 22, 2021

BancorpSouth  And 3 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

(VIANEWS) - BancorpSouth (BXS), Danaher Corporation (DHR), Heritage-Crystal Clean (HCCI) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. BancorpSouth (BXS)

57.4% sales growth and 10.33% return on equity

BancorpSouth Bank provides commercial banking and financial services to individuals and small-to-medium size businesses.

BancorpSouth's sales growth this year is expected to be 16.8% and 47.4% for next year.

Year-on-year quarterly revenue growth grew by 11.9%, now sitting on 1.03B for the twelve trailing months.

Volume

Today's last reported volume for BancorpSouth is 3386760 which is 264.46% above its average volume of 929232.

BancorpSouth's sales growth for the next quarter is 57.4%. The company's growth estimates for the present quarter and the next is a negative 7.2% and negative -155.1%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 10.33%.

Volatility

BancorpSouth's last day, last week, and last month's current volatility was 0.79%, 0.96%, and 1.08%, respectively.

BancorpSouth's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.20% (day), 1.61% (last week), and 2.15% (last month), respectively.

BancorpSouth's Stock Yearly Top and Bottom Value

BancorpSouth's stock is valued at $28.48 at 01:22 EST, way below its 52-week high of $35.59 and way above its 52-week low of $18.11.

BancorpSouth's Moving Average

BancorpSouth's value is above its 50-day moving average of $28.26 and below its 200-day moving average of $29.73.

2. Danaher Corporation (DHR)

12.5% sales growth and 13.98% return on equity

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide.

Danaher Corporation's sales growth this year is anticipated to be 28.7% and 5.4% for next year.

Year-on-year quarterly revenue growth grew by 36.3%, now sitting on 26.72B for the twelve trailing months.

Volume

Today's last reported volume for Danaher Corporation is 1839120 which is 14.37% below its average volume of 2147800.

Danaher Corporation's sales growth is a negative 0% for the present quarter and 12.5% for the next. The company's growth estimates for the present quarter and the next is 25% and 14.9%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 13.98%.

Volatility

Danaher Corporation's last day, last week, and last month's current volatility was 0.30%, 1.18%, and 0.80%, respectively.

Danaher Corporation's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.42% (day), 1.90% (last week), and 1.58% (last month), respectively.

Danaher Corporation's Stock Yearly Top and Bottom Value

Danaher Corporation's stock is valued at $324.70 at 01:22 EST, below its 52-week high of $333.96 and way higher than its 52-week low of $201.44.

Danaher Corporation's Moving Average

Danaher Corporation's worth is above its 50-day moving average of $317.70 and way above its 200-day moving average of $266.27.

3. Heritage-Crystal Clean (HCCI)

12% sales growth and 11.79% return on equity

Heritage-Crystal Clean, Inc., through its subsidiary, Heritage-Crystal Clean, LLC, provides parts cleaning, hazardous and non-hazardous waste, and used oil collection services to small and mid-sized customers in the industrial and vehicle maintenance sectors in the United States and Canada.

Heritage-Crystal Clean's sales growth this year is expected to be 20.1% and 0.2% for next year.

Year-on-year quarterly revenue growth grew by 47.5%, now sitting on 441.83M for the twelve trailing months.

Volume

Today's last reported volume for Heritage-Crystal Clean is 74138 which is 48.61% above its average volume of 49887.

Heritage-Crystal Clean's sales growth is a negative 0% for the present quarter and 12% for the next. The company's growth estimates for the ongoing quarter and the next is 244.4% and 106.9%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 11.79%.

Volatility

Heritage-Crystal Clean's last day, last week, and last month's current volatility was 5.12%, 2.53%, and 1.47%, respectively.

Heritage-Crystal Clean's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 4.14% (day), 2.41% (last week), and 2.75% (last month), respectively.

Heritage-Crystal Clean's Stock Yearly Top and Bottom Value

Heritage-Crystal Clean's stock is valued at $27.94 at 01:22 EST, way below its 52-week high of $34.91 and way above its 52-week low of $12.60.

Heritage-Crystal Clean's Moving Average

Heritage-Crystal Clean's worth is under its 50-day moving average of $28.76 and below its 200-day moving average of $28.92.

4. W.R. Grace & Co. (GRA)

7.8% sales growth and 16.68% return on equity

W. R. Grace & Co., through its subsidiaries, produces and sells specialty chemicals and materials worldwide.

W.R. Grace & Co.'s sales growth this year is anticipated to be 11.5% and 6.6% for next year.

Year-on-year quarterly revenue growth grew by 22.5%, now sitting on 1.86B for the twelve trailing months.

Volume

Today's last reported volume for W.R. Grace & Co. is 2313050 which is 339.86% above its average volume of 525857.

W.R. Grace & Co.'s sales growth for the next quarter is 7.8%. The company's growth estimates for the present quarter and the next is 76.8% and 29.5%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 16.68%.

Volatility

W.R. Grace & Co.'s last day, last week, and last month's current volatility was 0.04%, 0.02%, and 0.04%, respectively.

W.R. Grace & Co.'s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 0.06% (day), 0.06% (last week), and 0.13% (last month), respectively.

W.R. Grace & Co.'s Stock Yearly Top and Bottom Value

W.R. Grace & Co.'s stock is valued at $69.98 at 01:22 EST, under its 52-week high of $69.99 and way higher than its 52-week low of $38.70.

W.R. Grace & Co.'s Moving Average

W.R. Grace & Co.'s worth is above its 50-day moving average of $69.58 and above its 200-day moving average of $67.01.

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Frontier AI Slowdown Call Splits Industry, Rattles Capex-Sensitive Markets
Anthropic's Dario Amodei publicly called for a coordinated global slowdown in frontier AI development, a stance Microsoft echoed with a 'humanist' AI code of conduct, but Nvidia and Meta's CEOs rejected any coordinated pause days later, exposing a widening rift between safety-focused and growth-focused AI leaders. The dispute landed amid growing financial scrutiny of AI infrastructure spending — a hyperscaler capex analysis, FTC warnings against antitrust waivers for AI firms, and an 8.6% single-day stock drop in GE Vernova tied directly to the slowdown remarks — signaling investors are newly nervous about whether the AI capex boom (including Alphabet's projected $701B revenue narrative) can be justified if the pace of development itself becomes contested.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Berkshire Hathaway
Both facts report Berkshire Hathaway's cash position on 2026-01-01 with identical observation timestamps, but claim vastly different values: 380 billion USD vs 400 USD. These cannot both be true for the same entity at the same point in time. The magnitude of the discrepancy (a factor of ~10^9) rules out rounding, unit conversion, or methodological differences.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,983
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,983 facts checked against source5,304 source documents archived
Query this data → isubstrate.com